VX1 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Vertex Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 420.55 EUR 2.35%

Market Cap: €108.6B

V	Vertex Pharmaceuticals Inc F:VX1	US
	Cadence Design Systems Inc NASDAQ:CDNS	US
	International Consolidated Airlines Group SA LSE:IAG	UK
W	Walmart Inc XMUN:WMT	US
	E.ON SE F:EOAA	DE

Profitability Summary

Vertex Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

86%

Strong 3Y Average Gross Margin

86%

Declining Gross Margin

88% > 86%

Exceptional Operating Margin

39%

Strong 3Y Average Operating Margin

41%

Declining Operating Margin

47% > 39%

Exceptional Net Margin

36%

Sustainable 3Y Average Net Margin

20%

Net Margin is Increasing

35% > 36%

Exceptional Free Cash Flow Margin

30%

Strong 3Y Average Free Cash Flow Margin

16%

Declining Free Cash Flow Margin

41% > 30%

Positive ROE

24%

Positive 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.